Effect of Rapid Transfusion With Fluid Management System (FMS) on Plasma Potassium in Liver Transplantation Recipients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01331889|
Recruitment Status : Completed
First Posted : April 8, 2011
Last Update Posted : July 11, 2016
|Condition or disease|
|Condition Requiring Rapid Transfusion During Liver Transplantation Surgery|
|Study Type :||Observational|
|Actual Enrollment :||10 participants|
|Official Title:||Potassium Change in the Fluid Management System (FMS) Reservoir and Its Effect on the Plasma Potassium Concentration During Liver Transplantation Surgery|
|Study Start Date :||October 2011|
|Actual Primary Completion Date :||March 2015|
|Actual Study Completion Date :||April 2016|
plasma potassium concentrations in the Fluid Management System (FMS) reservoir, arterial blood, and central venous blood
- potassium concentration in the Fluid Management System (FMS) reservoir [ Time Frame: after transfusion of 150 ml of blood mixture ]During bolus transfusion (300ml) of blood mixture, blood sample is taken from the side port of infusion line of Fluid Management System (FMS) when 150 ml of blood mixture was transfused. Because the priming volume of the internal circuit is approximately 100 ml, blood sample that was taken after 150 ml transfusion represents the content in the reservoir.
- plasma potassium of the patient [ Time Frame: before and after transfuison of 300 ml of blood mixture ]Just before transfusion starts, blood samples are taken from the central venous catheter and arterial line at the same time to measure baseline values. At the immediate end of transfusion, blood samples are taken again from the same sites to measure the resultant changes.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01331889
|Korea, Republic of|
|Seoul National University Hospital|
|Seoul, Korea, Republic of|
|Principal Investigator:||Chul-Woo Jung, MD. PhD||Seoul National University Hospital|